Markedly elevated cell turnover is characteristic of small, deeply invasive carcinomas of the colorectum

Cancer

Volumn 85, Issue 4, 1999, Pages 796-802

  Takahashi, Hiroyuki ^a   Mitomi, Hiroyuki ^a,b   Igarashi, Masahiro ^a   Katsumata, Tomoe ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Bcl 2; C Ki ras; Cathepsin G; Deep invasion; Ki 67; P53; Small colorectal carcinoma

Indexed keywords

CATHEPSIN G; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MITOSIS INDEX; ONCOGENE K RAS; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CATHEPSIN D; CATHEPSINS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECTAL NEOPLASMS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033558296     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990215)85:4<796::AID-CNCR6>3.0.CO;2-3     Document Type: Article

References (26)

1. Welin S, Youker J, Spratt JS Jr. The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmö technique). AJR Am J Roentgenol 1963;90:673-87.
2. Bolin S, Nilsson E, Sjödahl R. Carcinoma of the colon and rectum-growth rate. Ann Surg 1983;198:151-8.
3. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-6.
4. Takano Y, Saegusa M, Ikenaga M, Mitomi H, Okayasu I. Apoptosis of colon cancer: comparison with Ki-67 proliferative activity and expression of p53. J Cancer Res Clin Oncol 1996;122:166-70.
5. Ikenaga M, Takano Y, Saegusa M, Ohtani Y, Hiki Y, Kakita A, et al. Apoptosis of colon cancers assessed by in situ DNA nick end-labeling method. Pathol Int 1996;46:33-7.
6. Ganesh S, Sier CFM, Griffioen G, Vloedgraven HJM, de Boer A, Welvaart K, et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 1994;54:4065-71.
7. Noh D-Y, Lee YH, Kim SS, Kim YI, Ryu S-H, Sun P-G, et al. Elevated content of phospholipase C-γ 1 in colorectal cancer tissues. Cancer 1994;73:36-41.
8. Weiss G, Kronberger P, Conrad F, Bodner E, Wachter H, Reibnegger G. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res 1993;53:260-5.
9. Rothbauer E, Mann K, Wiebecke B, Borlinghaus P, Lamerz R, Pratschke E, et al. Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas. Klin Wochenschr 1989;67:518-23.
10. Smith DR, Ji C-Y, Goh H-S. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 1996;74:216-23.
11. Mosnier J-F, Perret AG, Vindimian M, Dumollard J-M, Balique J-G, Perpoint B, et al. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 1996;120:654-9.
12. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
13. Andreyev HJN, Tilsed JVT, Cunningham D, Sampson SA, Norman AR, Schneider HJ, et al. K-ras mutations in patients with early colorectal cancers. Gut 1997;41:323-9.
14. Moerkerk P, Arends JW, van Driel M, de Bruine A, de Goeij A, ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994; 54:3376-8.
15. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 1994;54:2841-4.
16. Hasegawa H, Ueda M, Watanabe M, Teramoto T, Mukai M, Kitajima M. K-ras gene mutations in early colorectal cancer . . . flat elevated vs polyp-forming cancer . . . Oncogene 1995;10:1413-6.
17. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, et al. Flat-elevated colorectal neoplasms exhibit a high malignant potential. Oncology 1996;53:89-93.
18. Sada M, Mitomi H, Igarashi M, Katsumata T, Saigenji K, Okayasu I. The laterally spreading tumor with a granular appearance is a distinctive subtype of colorectal neoplasia. Scand J Gastroenterol. In press.
19. Jass JR, Sobin LH. WHO histological typing of intestinal tumors. 2nd edition. Berlin: Springer-Verlag, 1989.
20. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-35.
21. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
22. Yamashita K, Tatebayashi T, Shinoda H, Okayasu I. Simplified rapid non-radioactive PCR-SSCP method applied to K-ras mutation analysis. Pathol Int 1996;46: 801-4.
23. Garcia M, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990;5:1809-14.
24. Leto G, Gebbia N, Rausa L, Tumminello FM, Cathepsin D in the malignant progression of neoplastic diseases [review]. Anticancer Res 1992;12:235-40.
25. Větvička V, Věktvičková J, Fusek M. Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett 1994;79:131-5.
26. Stewart AJ, Piggott NH, May FEB, Westley BR. Mitogenic activity of procathepsin D purified from conditioned medium of breast-cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer 1994;57: 715-8.